Lime Chemicals Limited

As of June 30, 2026, Lime Chemicals Limited carries a market capitalization of 95.36M, placing it among publicly traded companies globally. Its enterprise value stands at 95.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Lime Chemicals Limited has 6.50M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.83 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 95.36M versus a market cap of 95.36M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

As of the close on October 22, 2026, Lime Chemicals Limited's stock has declined approximately 14.87% over the past 52 weeks. The 50-day moving average sits at 14.23, while the 200-day moving average is 13.95.

Over the twelve months ended June 30, 2026, Lime Chemicals Limited generated 114.94M in revenue and converted that into -117,000.00 in net income, yielding earnings per share of -0.02. EBITDA reached -1.21M, while operating income came in at -1.99M.

Over the twelve months ended June 30, 2026, Lime Chemicals Limited posted a gross margin of 24.15, reflecting its pricing power and cost economics. The operating margin of -1.73 and net profit margin of -0.10 provide insight into operational efficiency.